• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP ITALIA S.R.L. - CRM FACILITY REPLY 200; IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP ITALIA S.R.L. - CRM FACILITY REPLY 200; IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT) Back to Search Results
Model Number REPLY 200 DR
Device Problem Loss of Data (2903)
Patient Problem No Information (3190)
Event Date 11/13/2017
Event Type  malfunction  
Manufacturer Narrative
The device model involved in this mdr report is not approved in the united states; however, it is similar to a device manufactured by livanova that was cleared or approved by fda for marketing in the united states.
 
Event Description
Reportedly, on (b)(6) 2017 a pacemaker replacement procedure was performed.While still in the box, the subject device was reprogrammed to operate at 50 min-1 in aai mode.The pacemaker was then taken out of the package and connected to the atrial and ventricular leads.After the pocket was closed, when the device was interrogated, it was found that aida had not been activated.After ¿aida programming¿ was manually performed in the aida screen, the programming session ended.The pacemaker was then re-interrogated, but aida had still not been activated.The pacing mode was reprogrammed to safer.This time, aida had been activated and statistical data such as the pacing rate had been recorded.With the pacing mode remaining in safer, the basic rate was programmed to 50 min-1 (max.130 min-1).On (b)(6) 2017 the device was interrogated; however, no data had been recorded in the device memory.The pacemaker was reprogrammed back to aai mode without no further examination regarding the behavior related to aida.After the pacemaker was reprogrammed from safer mode to operate in aai mode at 50 min-1, aida programming was performed to ensure a proper activation of aida.
 
Manufacturer Narrative
Please refer to the attached analysis report.
 
Event Description
Reportedly, on (b)(6) 2017 a pacemaker replacement procedure was performed.While still in the box, the subject device was reprogrammed to operate at 50 min-1 in aai mode.The pacemaker was then taken out of the package and connected to the atrial and ventricular leads.After the pocket was closed, when the device was interrogated, it was found that aida had not been activated.After ¿aida programming¿ was manually performed in the aida screen, the programming session ended.The pacemaker was then re-interrogated, but aida had still not been activated.The pacing mode was reprogrammed to safer.This time, aida had been activated and statistical data such as the pacing rate had been recorded.With the pacing mode remaining in safer, the basic rate was programmed to 50 min-1 (max.130 min-1).On (b)(6) 2017 the device was interrogated; however, no data had been recorded in the device memory.The pacemaker was reprogrammed back to aai mode without no further examination regarding the behavior related to aida.After the pacemaker was reprogrammed from safer mode to operate in aai mode at 50 min-1, aida programming was performed to ensure a proper activation of aida.
 
Manufacturer Narrative
Preliminary analysis did not reveal any device malfunction.
 
Event Description
Reportedly, on (b)(6) 2017 a pacemaker replacement procedure was performed.While still in the box, the subject device was reprogrammed to operate at 50 min-1 in aai mode.The pacemaker was then taken out of the package and connected to the atrial and ventricular leads.After the pocket was closed, when the device was interrogated, it was found that aida had not been activated.After ¿aida programming¿ was manually performed in the aida screen, the programming session ended.The pacemaker was then re-interrogated, but aida had still not been activated.The pacing mode was reprogrammed to safer.This time, aida had been activated and statistical data such as the pacing rate had been recorded.With the pacing mode remaining in safer, the basic rate was programmed to 50 min-1 (max.130 min-1).On (b)(6) 2017 the device was interrogated; however, no data had been recorded in the device memory.The pacemaker was reprogrammed back to aai mode without no further examination regarding the behavior related to aida.After the pacemaker was reprogrammed from safer mode to operate in aai mode at 50 min-1, aida programming was performed to ensure a proper activation of aida.
 
Manufacturer Narrative
Additional analysis confirmed that device memory was unexpectedly deactivated.
 
Event Description
Reportedly, on (b)(6) 2017 a pacemaker replacement procedure was performed.While still in the box, the subject device was reprogrammed to operate at 50 min-1 in aai mode.The pacemaker was then taken out of the package and connected to the atrial and ventricular leads.After the pocket was closed, when the device was interrogated, it was found that aida had not been activated.After ¿aida programming¿ was manually performed in the aida screen, the programming session ended.The pacemaker was then re-interrogated, but aida had still not been activated.The pacing mode was reprogrammed to safer.This time, aida had been activated and statistical data such as the pacing rate had been recorded.With the pacing mode remaining in safer, the basic rate was programmed to 50 min-1 (max.130 min-1).On (b)(6) 2017 the device was interrogated; however, no data had been recorded in the device memory.The pacemaker was reprogrammed back to aai mode without no further examination regarding the behavior related to aida.After the pacemaker was reprogrammed from safer mode to operate in aai mode at 50 min-1, aida programming was performed to ensure a proper activation of aida.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REPLY 200
Type of Device
IMPLANTABLE PULSE GENERATOR, PACEMAKER (NON-CRT)
Manufacturer (Section D)
SORIN GROUP ITALIA S.R.L. - CRM FACILITY
parc d'affaires noveos 4 avenue réaumur
.
clamart 92140
FR  92140
Manufacturer (Section G)
SORIN GROUP ITALIA SRL VIA CRESCENTINO 13040 SALUGGIA ITALY
parc d'affaires noveos 4 avenue réaumur
.
clamart 92140
FR   92140
Manufacturer Contact
elodie vincent
parc d'affaires noveos 4 avenue réaumur
.
clamart 92140
FR   92140
0146013665
MDR Report Key7107605
MDR Text Key95747416
Report Number1000165971-2017-00915
Device Sequence Number1
Product Code LWP
UDI-Device Identifier08031527012933
UDI-Public(01)08031527012933(11)170907(17)190907
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Medical Technologist
Type of Report Initial,Followup,Followup,Followup
Report Date 11/15/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date09/07/2019
Device Model NumberREPLY 200 DR
Device Catalogue NumberREPLY 200 DR
Device Lot NumberS0280
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Distributor Facility Aware Date11/15/2017
Event Location Hospital
Initial Date Manufacturer Received 11/15/2017
Initial Date FDA Received12/12/2017
Supplement Dates Manufacturer Received12/08/2017
01/08/2018
03/06/2018
Supplement Dates FDA Received01/03/2018
02/04/2018
03/27/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/07/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-